Reset filter

PS12(PM) Position statement on the use of ketamine in the management of chronic non-cancer pain

ANZCA_2022-Aus-Gov-Federal-election-priorities_P2

PS12(PM)BP Position Statement on the use of ketamine in the management of CNCP Background paper

ANZCA Annual Report 2020 (full financials)

ANZCA Annual Report 2020 (full financials)

8-Specific-clinical-situations-Watermarked

FPM Procedures Endorsement Program Curriculum

2-0-Assessment-Watermarked

FPM by-law 16 - Recognition as a specialist (SIMG)

Examination reports

Intellectual property policy

First  < Prev   ... 91 92    Next >  Last Pages: 91 of 92